Discontinuing Medications: When, Why, and How-to

Discontinuing Medications: When, Why, and How-to

Table 1 – Reasons for psychotropic medication discontinuationTable 1 – Reasons for psychotropic medication discontinuation
Table 2 – Pharmacokinetic and pharmacodynamic considerationsTable 2 – Pharmacokinetic and pharmacodynamic considerations
Table 3 – Common withdrawal symptoms with abrupt discontinuationTable 3 – Common withdrawal symptoms with abrupt discontinuation

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

Premiere Date: July 19, 2013

Expiration Date: July 19, 2014

This activity offers CE credits for:

1. Physicians (CME)
2. Other

Activity Goal

The goal of this activity is to present information on why a patient might decide to discontinue psychotropics as well as best strategies for discontinuing, and why medication discontinuation might be necessary.

Learning Objectives

At the end of this CE activity, participants should be able to:

1. Describe the reasons a patient might decide to discontinue medication.

2. Describe the primary recommendations of practice guidelines for several psychiatric disorders.

3. Develop and use a planned discontinuation to achieve optimum outcomes.

4. Recognize when medication discontinuation is warranted.

Target Audience

This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.

Credit Information

CME Credit (Physicians): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of CME Outfitters, LLC, and Psychiatric Times. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians.

CME Outfitters designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Nurse Practitioners and Physician Assistants: AANPCP and AAPA accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer-review process.

The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

John J. Miller, MD, was on the Speakers Bureau for Pfizer Inc, until April 26, 2012. He is currently on the Speakers Bureau for AstraZeneca, Sunovion, and Forest; is a consultant for AstraZeneca and Sunovion; and holds Pfizer stock in the amount of $3552.

David S. Janowsky, MD (peer/content reviewer), has no disclosures to report.

Applicable Psychiatric Times staff have no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, and the faculty do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.